The Journal of Clinical Psychiatry

Page 433

More JCP Articles

Letter to the Editor

Dr. Brawman-Mintzer and Colleagues Reply to “Sedative Effects of Low-Dose Risperidone in GAD Patients and Risk of Drug Interactions”

August 1, 2006

Olga Brawman-Mintzer , Rebecca G. Knapp , Paul J. Nietert

Letter to the Editor

Initial Dosing Strategies for Long-Acting Injectable Risperidone

August 1, 2006

Mark W. Viner , Jeremy M. Matuszak , Linda J. Knight

Letter to the Editor

Sedative Effects of Low-Dose Risperidone in GAD Patients and Risk of Drug Interactions

August 1, 2006

Miloslav Kopecek , Pavel Mohr , Tomas Novak

Educational Activity

Outcomes to Monitor When Treating Bipolar Disorder or Schizophrenia

August 1, 2006

Philip D. Harvey

Educational Activity

Schizophrenia: A Neurodevelopmental or a Neurodegenerative Disorder

August 1, 2006

Dolores Malaspina

Educational Activity

Management of Bipolar & Substance Abuse

August 1, 2006

Read a presentation reviewing data from 4 randomized, controlled trials of pharmacotherapy discussing the management of bipolar disorder and substance abuse.

E. Sherwood Brown

Article

Adolescent Substance Abuse and Psychiatric Comorbidities

July 14, 2006

Deborah Deas

ASCP Corner

ASCP Administers 10th Certification Exam

July 14, 2006

ASCP Examination Committee

Original Research

Association Between the Accessibility to Lethal Methods and Method-Specific Suicide Rates: An Ecological Study in Taiwan.

July 14, 2006

Jin-Jia Lin , Tsung-Hsueh Lu

Original Research

Associations Between Bipolar Disorder and Metabolic Syndrome: A Review

July 14, 2006

Valerie Taylor , Glenda MacQueen

Article

Cognitive Impairment and Functional Outcome in Schizophrenia and Bipolar Disorder

July 14, 2006

Michael F. Green

Original Research

Comparison of Quetiapine and Risperidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Flexible-Dose, 8-Week Study

July 14, 2006

Kate X. Zhong , Dennis E. Sweitzer , Robert M. Hamer , et al

« 1 … 431 432 433 434 435 … 755 »